R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Associate Director, Medical Operations

Biology & BiotechConfirmed live in the last 24 hours
Full-timeMunich, GermanyNo salary listed

About the Job

Requirements

  • An advanced degree (MD, Ph.D., PharmD, or relevant life sciences/business degree) is preferred, not required.
  • Have 8 or more years of Medical Affairs operations, project or portfolio management, or equivalent experience in biotech or pharma, including leadership of complex cross-functional work.
  • Have a solid understanding of healthcare systems, evidence generation, and medical governance requirements.
  • Demonstrate leadership, strategic thinking, coaching, and stakeholder engagement skills with a patient-focused mindset.
  • Be able to work in a fast-paced, evolving environment while managing multiple priorities.
  • Be proficient in Medical Affairs systems and analytics, such as Datavision, Veeva CRM, medical information databases, and grants management platforms.
  • Know industry regulations, including the PhRMA Code, Sunshine Act, GPP, FDA, and ACCME, and how they affect Medical Affairs operations.
  • Demonstrate ownership of sizeable budgets, vendor ecosystems, and complex contract governance.
  • Be able to liaise with cross-functional teams, including Commercial and Sales, Legal, Compliance, Finance, and IT.
  • Have organizational, communication, and problem-solving skills to manage operations and drive efficiency.
  • Be able to maintain accurate records and compliance documentation.

Responsibilities

  • Own the Medical Affairs operating model for Germany and set priorities, governance, ways of working, and performance measures.
  • Provide final operational oversight for advisory boards, symposia, and major medical events, including contracting, budget, compliance, and escalation management.
  • Lead continuous improvement and regionalization initiatives; identify risks, remove bottlenecks, and embed sustainable process changes.
  • Translate strategic plans into integrated execution roadmaps.
  • Own the German Medical Affairs budget and provide decision-ready insights to leadership.
  • Set local contracting and vendor-management strategy, including performance reviews and risk mitigation.
  • Direct the portfolio of Medical Affairs initiatives, ensuring business cases, milestones, resources, dependencies, and risks are actively managed.
  • Coach project leads and operational colleagues on planning discipline, stakeholder management, and execution excellence.
  • Set the roadmap for Medical Affairs systems, analytics, and automation, including CRM reporting in partnership with the German Commercial Senior Director and relevant European teams.
  • Ensure robust oversight of HCP engagement, grants, and event processes, with clear controls, records, and reporting.
  • Partner with Legal, Compliance, Regulatory, Finance, and IT to anticipate and manage operational and compliance risks.
  • Own the operational strategy for German congresses and major external engagements with the European Director, Medical Operations & Project Management.

Desired Qualifications

  • People leadership.
  • Experience in oncology or precision medicine.
  • Experience working across German and European Medical Affairs organizations.
  • Prior experience working in a fast-paced, matrixed biotech or pharmaceutical environment.
  • Familiarity with emerging digital tools for Medical Affairs operations and engagement.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs